Edition:
United States

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Navidea Biopharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

26 Aug 2016 Reuters Investment Profile 12 $20.00

NAVB: Due Diligence Review: Forensic Earnings and Valuation

Reports provide superior value and incorporate critical data from the Financial Footnotes and MD&A that other firms miss. The...

29 Aug 2016 New Constructs, LLC 10 $25.00

Thomson Reuters Stock Report - Navidea Biopharmaceuticals Inc (NAVB-A)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

28 Aug 2016 Thomson Reuters Stock Report 12 $25.00

ValuEngine Rating and Forecast Report for NAVB

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

28 Aug 2016 ValuEngine, Inc. 11 $25.00

Value Graph: NAVIDEA BIOPHARM -- NAVB

26 Aug 2016 Ford Investor Services, Inc. 1 $12.00

NAVIDEA BIOPHARMACEUTICALS INC (NAVB=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

20 Aug 2016 Pechala's Reports 2 $25.00

"The Economy Matters" Report for NAVB: the economy's impact on NAVB's price and risk, featuring the powerful Economic Climate Rating and the new MacroRisk "Stoplight" and Risk Correspondence Score

"The Economy Matters"(r) Reports feature the powerful Economic Climate Rating and MacroRisk "Stoplight" to help you in your a...

15 Aug 2016 MacroRisk Analytics/EconomicInvestor 8 $25.00

Navidea Biopharmaceuticals, Inc. (NAVB) - Financial and Strategic SWOT Analysis Review

Navidea Biopharmaceuticals, Inc. (NAVB) - Financial and Strategic SWOT Analysis Review Summary Navidea Biopharmaceuticals, In...

05 Aug 2016 GlobalData 76 $300.00

NAVB.A - Event Transcript of Navidea Biopharmaceuticals Inc conference call, Aug. 04, 2016 / 8:30AM ET

Edited Event Transcript of NAVB.A conference call, Aug. 04, 2016 / 8:30AM ET Boston, Aug 15, 2016 (Thomson StreetEvents...

04 Aug 2016 Thomson Reuters StreetEvents 13 $75.00

Wright Investors Service Comprehensive Report for Navidea Biopharmaceuticals Incorporated

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

29 Jul 2016 Wright Reports 61 $75.00